NASDAQ:ORMP

Oramed Pharmaceuticals Stock Dividends

Healthcare > Biotechnology

Buy ORMP

*Your capital is at risk

$4.17

+0.160 (+3.99%)

At Close: Jun 23, 2026

ORMP Dividends Insights

ORMP pays dividends . Last paid amount was $0.250 at Jan 26, 2026. As of today, dividend yield (TTM) is 6.00%.

Dividend Score Premium

Avoid dividend cuts
with our Dividend Score
Start 7-Day Free Trial

AI Analysis of ORMP

AI-Powered Dividend Insights

Built on AI-powered analysis of yield strength, recent news, payout trends, and 10-year dividend growth consistency.

Dividend Yield Range

The Dividend Yield Range is the range of values in which a stock’s dividend yield has fluctuated within a specified period, often a year. It represents the variation between the highest and lowest dividend yields observed during that time frame.

AI Analysis of ORMP

AI-Powered Market Insights

New!

Dividend Analysis

Key Stats

Dividend Yield (TTM)	6.00%
Frequency
1Y Growth	0%
Payout Ratio	0
Amount Per Share	$0.250
Oramed Pharmaceuticals Inc. has not yet announced its next dividend date. Last payment date was: Jan 26, 2026.

ORMP Dividend Payout History

To ensure a understanding of ORMP's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.

#	Declaration Date	Ex-Date	Pay Date	Amount	Yield
1	Jan 16, 2026	Jan 16, 2026	Jan 26, 2026	$0.250	7.18%

Requires Login

Dividend Sustainability

Unable to generate commentary due to missing data.

DSS - Sustainability score

N/A

DSGP - Growth potential

N/A

ORMP Dividend Calculator

Dividend Calculator is designed to forecast the potential returns from ORMP dividends based on your individual investment size or the number of shares you own. Simply enter your total investment amount to see the cumulative dividend payment you could receive over a specified period.
Read how to invest in ORMP stock here.

Comparing ORMP to Sector and Country

ORMP pays a solid dividend yield of 6.00%, which is higher than the average of the bottom 25% of dividend payers in the US market (0.567%). ORMP’s dividend yield is lower than the average of the top 25% of dividend payers in the Healthcare sector in the US market (8.84%), which means that there are more attractive dividend stocks to consider.

ORMP Stock Competitors

Symbol	Company Name	Market Cap	Amount Per Share	Dividend Yield (TTM)	Payout Ratio (TTM)
ORMP	Oramed Pharmaceuticals Inc.	170.662M	$0.250	6.00%	-
UTMD	Utah Medical Products	210.592M	$0.310	1.89%	36.46%

FAQ

What factors can affect the amount of ORMP's dividend payments?

The amount of ORMP's dividends can fluctuate based on several factors, including the company's financial performance, earnings, cash flow, capital requirements, and overall market conditions. Changes in ORMP sector's trends, interest rate shifts, and the company's operational adjustments can also influence dividend decisions.

Can dividends from ORMP stock be automatically reinvested?

If ORMP offers a Dividend Reinvestment Plan (DRIP), shareholders may have the option to automatically reinvest dividends to purchase additional shares. Please check with your brokerage for the availability and details of such a plan. Here's an easy guide on how to buy ORMP stock.

How often does ORMP pay dividend?

Oramed Pharmaceuticals Inc. (ORMP) pays dividends . The most recent payout was on Jan 26, 2026.

How much does ORMP pays per share?

The last recorder (Jan 16, 2026) dividend per share was $0.250.

What is ORMP dividend growth rate?

Over the last year, Oramed Pharmaceuticals Inc. has witnessed growth rate of 0% . Looking back over the past 3 years, this growth rate has been 0%. Furthermore, examining the past 5 years, Oramed Pharmaceuticals Inc. has maintained an average Dividends Per Share Growth Rate of 0%.

ABOUT ORAMED PHARMACEUTICALS INC.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for the treatment of individuals with diabetes. It is also developing ORMD-0901, an oral glucagon-like peptid...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
IDYA $28.98	18.12%	Jun 12
DHI $146.71	6.39%	Jun 10
E ETD $20.67	4.79%	Jun 05
EAT $140.46	16.94%	Jun 05
TPR $140.47	7.16%	Jun 04

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by